Gain Therapeutics CEO Gene Mack takes interim CFO role after Fuggetta resignation
GANX•Gain Therapeutics named President and CEO Gene Mack interim CFO effective Oct. 1, 2026, after Senior Vice President of Finance Gianluca Fuggetta steps down on Sept. 30. Mack will handle principal financial and accounting duties while the company searches for a permanent replacement.
1. Interim finance leadership
Gain Therapeutics named President and CEO Gene Mack interim CFO effective Oct. 1, 2026. Senior Vice President of Finance Gianluca Fuggetta will step down as principal financial and accounting officer on Sept. 30, and Mack will assume those duties while the company searches for a permanent replacement.
